Amisulpride and symptomatic bradycardia: a case report

doi:10.1016/j.genhosppsych.2013.12.005

Chia Nan University of Pharmacy & Science Institutional Repository > 智慧生活學院 > 醫務管理系(所) > 期刊論文 > Item 310902800/29758

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/29758

標題:	Amisulpride and symptomatic bradycardia: a case report
作者:	Huang, Li-Chung Huang, Li-Yen Tseng, Shih-Yen Hou, Yuh-Ming Hsiao, Cheng-Cheng
貢獻者:	醫務管理系
關鍵字:	Badycardia Psychotic disorder Amisulpride Adverse drug reaction
日期:	2015-09
上傳時間:	2016-04-19 19:07:08 (UTC+8)
出版者:	Elsevier Science Inc
摘要:	Objective: Amisulpride is a second-generation antipsychotic agent indicated for the treatment of schizophrenia and other major psychotic illnesses. Amisulpride-induced bradycardia is a rare condition of unknown etiology and mechanism. Asymptomatic bradycardia has been associated with amisulpride in only two cases. In our case, the association was rated as "probable" on the Naranjo adverse drug reaction probability scale.Method: Case report.Results: A 45-year-old male patient developed symptomatic bradycardia during usage of amisulpride (400800 mg/day), which dramatically improved after the complete termination of amisulpride usage. The psychiatric condition remained relatively stable without bradycardia after administration of another antipsychotic agent [risperidone (3 mg/day)].Conclusion: This is the first case report of symptomatic bradycardia associated with the use of amisulpride. Although bradycardia is a rare adverse reaction to antipsychotics, this finding may alert psychiatrists and physicians to this antipsychotic drug side effect. Further study is needed to disclose the role of antipsychotics in bringing about symptomatic bradycardia. (C) 2015 Elsevier Inc. All rights reserved.
關聯:	General Hospital Psychiatry, v.37 n.5, Pages 497.e1–497.e2
Appears in Collections:	[醫務管理系(所)] 期刊論文

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	2257	View/Open

Loading...